シラミ治療の世界市場- 産業規模、シェア、動向、機会、予測、2018年～2028年：タイプ別、薬剤別、流通チャネル別、地域別、競合別分析

シラミ治療の世界市場は、2022年に10億1,000万米ドルと評価され、2028年までのCAGRは5.41%で、予測期間中に力強い成長が予測されています。

シラミ治療の世界市場は、シラミの蔓延の増加、シラミ管理に対する意識の高まり、革新的な治療ソリューションの開発など様々な要因によって、近年著しい成長と進化を遂げています。シラミの蔓延は、特に学校や保育園の子供たちの間で、世界的に広く蔓延している問題であり続けており、効果的な治療オプションが必要とされています。その結果、シラミ治療製品とサービスの世界市場は、この需要に応えるべく拡大しています。シラミ治療の世界市場の主な促進要因の1つは、製薬会社やヘルスケア企業が先進的でより効果的な治療法を導入するために継続的な研究開発に取り組んでいることです。ペディキュリサイドのような従来の化学薬品に基づく治療法は、その安全性と有効性に対する懸念から、監視の目を向けられています。その結果、自然療法やハーブ療法など、無害で無農薬の代替療法への需要が急増し、市場で人気を集めています。

さらに、市販の（OTC）シラミ治療薬が入手可能になったことで、消費者は処方箋を必要とせずにこれらの治療薬を入手し、使用することが容易になっています。このアクセスのしやすさは、シラミの蔓延に悩む個人や家族に便利な選択肢を提供することで、市場の成長に貢献しています。

世界市場はまた、シラミの診断と治療指導のためのデジタル・ソリューションと遠隔医療へのシフトを目の当たりにしており、個人が物理的なヘルスケア施設を訪れることなく専門家のアドバイスと治療計画を求めることをより便利にしています。この動向は広範なデジタルヘルスケアの動きと一致しており、市場の裾野をさらに広げています。

市場促進要因

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 シラミ治療の世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • タイプ別（アタマジラミ症、体部ジラミ症、陰部ジラミ症）
  • 薬剤別（OTC薬、処方薬）
  • 流通チャネル別（病院薬局、小売薬局、オンライン薬局）
  • 地域別
  • 企業別（2022年）
• 市場マップ
  • タイプ別
  • 医薬品別
  • 流通チャネル別
  • 地域別

第5章 アジア太平洋のシラミ治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 薬剤別
  • 流通チャネル別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のシラミ治療市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 薬剤別
  • 流通チャネル別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のシラミ治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 薬剤別
  • 流通チャネル別
  • 国別
• 北米国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のシラミ治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 薬剤別
  • 流通チャネル別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのシラミ治療薬市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 薬剤別
  • 流通チャネル別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 シラミ治療の世界市場SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Alliance Pharmaceuticals
• Omega Pharma（Perrigo Company）
• Prestige Brands Holdings Inc.
• Johnson & Johnson Private Limited
• Fleming Medical Ltd
• RID Lice（Oystershell Consumer Health, Inc）
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Lice Treatment Market has valued at USD 1.01 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.41% through 2028. The Global Lice Treatment Market has witnessed significant growth and evolution in recent years, driven by various factors such as increasing lice infestations, growing awareness about lice management, and the development of innovative treatment solutions. Lice infestations, particularly among children in schools and daycare settings, continue to be a prevalent issue worldwide, necessitating effective treatment options. As a result, the global market for lice treatment products and services has expanded to meet this demand. One of the key drivers of the Global Lice Treatment Market is the continuous research and development efforts by pharmaceutical and healthcare companies to introduce advanced and more efficacious treatment methods. Traditional chemical-based treatments like pediculicides are facing increasing scrutiny due to concerns about their safety and efficacy. Consequently, there has been a surge in the demand for non-toxic and pesticide-free alternatives, such as natural and herbal remedies, which are gaining popularity in the market.

Additionally, the availability of over the counter (OTC) lice treatment products has made it easier for consumers to access and use these treatments without the need for a prescription. This accessibility has contributed to the market's growth by providing a convenient option for individuals and families dealing with lice infestations.

The global market is also witnessing a shift toward digital solutions and telemedicine for lice diagnosis and treatment guidance, making it more convenient for individuals to seek professional advice and treatment plans without visiting a physical healthcare facility. This trend aligns with the broader digital healthcare movement and has further expanded the market's reach.

Key Market Drivers

Increasing Prevalence of Lice Infestations

The increasing prevalence of lice infestations has emerged as a significant driving force behind the robust growth of the global lice treatment market. Lice infestations, caused by tiny parasitic insects known as lice, have become a common problem in various parts of the world, especially among school-age children and their families. These infestations can spread rapidly through close personal contact, and their persistence has fueled the demand for effective treatment options.

In recent years, the prevalence of lice infestations has been on the rise due to several factors. First, changing social dynamics and increased mobility have created environments where lice can easily transfer from one host to another. Schools, daycare centers, and other communal spaces become hotbeds for lice transmission, making children and their families particularly vulnerable. Second, evolving lice strains have developed resistance to some traditional treatment methods, leading to treatment failures and the need for more innovative solutions. This resistance has prompted healthcare professionals and pharmaceutical companies to explore new approaches to lice treatment, spurring research and development efforts.

Moreover, awareness campaigns and educational initiatives have been instrumental in identifying lice infestations earlier. Parents, teachers, and healthcare providers are now better equipped to recognize the signs and symptoms of lice infestations, leading to quicker intervention. This heightened awareness has resulted in increased demand for lice treatment products and services, as early detection and treatment are crucial in managing and containing lice outbreaks. As the prevalence of lice infestations continues to rise globally, the market for lice treatment solutions is expected to remain robust. Companies are actively developing innovative, non-toxic, and pesticide-free treatments to address the growing concerns of consumers..

Growing Awareness and Education

Growing awareness and education have become significant catalysts behind the burgeoning growth of the global lice treatment market. In recent years, there has been a substantial increase in awareness and education regarding lice infestations, their prevention, and treatment options. This newfound knowledge has not only empowered individuals and families to better manage lice but has also driven the demand for lice treatment products and services.

Educational initiatives and awareness campaigns have played a pivotal role in disseminating information about lice infestations. Schools, healthcare organizations, and community groups have increasingly focused on educating parents, teachers, and students about the signs, symptoms, and risks associated with lice. These efforts have not only reduced the stigma associated with lice but have also normalized discussions surrounding their prevention and treatment.As a result of this heightened awareness, individuals are more proactive in identifying lice infestations at their early stages. Early detection is critical in managing lice outbreaks and preventing their spread to others. This has translated into an increased demand for lice treatment products, as individuals seek swift and effective solutions to address infestations in a timely manner.

Healthcare professionals, too, are better equipped to diagnose and treat lice infestations, thanks to improved education and training. They can offer informed guidance to patients and recommend suitable treatment options, contributing to the overall growth of the lice treatment market. Furthermore, the accessibility of information through the internet and social media has played a pivotal role in educating the public about lice. Websites, forums, and social media platforms offer a wealth of information, tips, and DIY remedies for lice treatment. While this has empowered individuals to take action, it has also led to increased awareness of the various lice treatment products available in the market.

Development of Innovative Treatment Solutions

The development of innovative treatment solutions has been a pivotal factor in propelling the global lice treatment market to new heights. In recent years, the market has witnessed a notable shift towards more effective, safe, and sustainable treatment methods, largely driven by advancements in scientific research and technology. Traditional chemical-based lice treatments, while effective, have faced growing concerns over their safety and the development of lice resistance. This has spurred pharmaceutical and healthcare companies to invest heavily in research and development efforts aimed at creating innovative solutions. The result has been a wave of pioneering treatments that have reshaped the market.

One notable trend in lice treatment innovation is the emergence of non-toxic and pesticide-free alternatives. Natural and herbal remedies have gained popularity among consumers who seek gentler and environmentally friendly options. These products are often perceived as safer for children and can be used without the worry of exposing them to harmful chemicals. As such, the development and marketing of these natural solutions have significantly expanded the lice treatment market.Cutting-edge technologies have also played a transformative role in lice treatment innovation. Devices that use heat or air to dehydrate and eliminate lice and their eggs have gained traction. These innovations offer a chemical-free and non-invasive approach to lice treatment, providing a more comfortable and efficient experience for both individuals and healthcare providers.

Furthermore, the incorporation of digital tools and telemedicine into lice treatment has made diagnosis and treatment guidance more accessible and convenient. Patients can now seek professional advice remotely, allowing for timely and accurate treatment recommendations.

Key Market Challenges

Lice Resistance to Treatment

One of the most formidable challenges confronting the global lice treatment market is the increasing resistance of lice to traditional treatment methods. Lice, those tiny parasitic insects that infest the scalps and hair of humans, have evolved to become remarkably resilient against many common chemical-based treatments. This resistance is a significant hindrance to the effectiveness of lice treatment solutions, leading to treatment failures, prolonged infestations, and growing frustration among affected individuals and their families.

Lice have developed resistance to pyrethroids, a class of synthetic chemicals commonly used in many over-the-counter (OTC) lice treatment products. This resistance has made these once-reliable treatments less effective, necessitating repeated applications and often resulting in incomplete eradication of the infestation. As a result, individuals and healthcare providers are finding it increasingly challenging to manage and eliminate lice infestations, driving the demand for more innovative and potent treatment options.

The development of resistance by lice is a complex biological process driven by factors such as genetic mutations and natural selection. Over time, the surviving lice that possess resistance to a particular treatment method pass on their resistant traits to future generations, creating a population of lice that are less susceptible to that treatment.

Safety and Toxicity Concerns

Safety and toxicity concerns have emerged as significant obstacles impeding the growth and development of the global lice treatment market. Lice infestations are a common problem, particularly among children, and the demand for effective treatment options is on the rise. However, many traditional lice treatment products contain chemical pesticides, giving rise to apprehensions about their safety, particularly when used on children.

One of the primary concerns associated with chemical-based lice treatments is the potential for adverse effects, particularly when applied to the sensitive scalps and skin of children. Some individuals may experience allergic reactions or skin irritations as a result of these chemical treatments, leading to discomfort and, in some cases, additional health complications.

Furthermore, the long-term health impacts of repeated exposure to chemical lice treatments remain a subject of ongoing research and debate. While these treatments are generally considered safe for short-term use when applied as directed, the cumulative effects of exposure to chemical pesticides over time are not yet fully understood. This lack of clarity raises concerns, especially among parents and caregivers who are increasingly seeking safer treatment alternatives for their children.

Key Market Trends

Accessibility of Over-the-Counter (OTC) Products

The accessibility of Over-the-Counter (OTC) lice treatment products has played a pivotal role in boosting the global lice treatment market. These readily available and convenient products have become a lifeline for individuals and families grappling with lice infestations. OTC lice treatments are easily accessible without the need for a prescription, making them a first-line choice for many consumers when they discover a lice infestation.

Pharmacies and retail stores stock a wide range of OTC lice treatment options, ranging from shampoos and lotions to combs and sprays. This availability ensures that consumers can quickly obtain the necessary treatment products, enabling them to initiate lice treatment promptly. The convenience of purchasing these products in local stores or online has significantly contributed to their popularity.

The simplicity of OTC lice treatment products further enhances their accessibility. Most OTC treatments come with easy-to-follow instructions, enabling individuals and caregivers to administer treatment without the need for specialized medical expertise. This user-friendliness empowers consumers to take immediate action when they suspect a lice infestation, contributing to early detection and intervention. Furthermore, the affordability of OTC lice treatment products makes them an attractive choice for many consumers. Unlike prescription treatments, which may be more expensive and require a doctor's visit, OTC options are often budget-friendly. This affordability ensures that lice treatment is within reach for a wide range of individuals and families, regardless of their financial circumstances. The convenience of OTC lice treatment extends beyond physical stores, as online shopping platforms offer an additional avenue for accessibility. Consumers can browse, compare, and purchase lice treatment products from the comfort of their homes, further simplifying the process.

Consumer Demand for Natural and Safe Products

Consumer demand for natural and safe lice treatment products has emerged as a significant driving force behind the growth of the global lice treatment market. In recent years, there has been a notable shift in consumer preferences towards products that are perceived as gentler, eco-friendly, and less harmful to health, particularly when dealing with sensitive issues like lice infestations.Traditional lice treatment products often contain chemical pesticides and synthetic compounds. While these products can be effective, they have raised concerns about their safety, especially when used on children. Parents and caregivers, in particular, have become increasingly cautious about the products they use on their loved ones, spurring the demand for safer alternatives.

Natural and herbal lice treatment remedies have gained immense popularity among consumers seeking non-toxic options. These products are often formulated using plant-based ingredients and essential oils known for their pest-repellent properties. Ingredients like tea tree oil, neem oil, and lavender oil are commonly found in these natural lice treatment products. Consumers are drawn to these products because they do not contain harsh chemicals and are perceived as being safer for children and the environment.

The demand for natural and safe lice treatment products has prompted companies in the lice treatment market to innovate and develop formulations that align with these consumer preferences. Many of these natural remedies are available as shampoos, sprays, or creams and are marketed as effective alternatives to chemical-based treatments. They not only offer peace of mind to consumers worried about exposing their children to potentially harmful chemicals but also cater to the growing trend of eco-consciousness and health awareness..

Segmental Insights

Type Insights

Based on the Type, the Pediculosis Capitis segment emerged as the dominant segment in the global market for Global Lice Treatment Market in 2022. Pediculosis Capitis are by far the most common and widespread form of lice infestation worldwide, especially among school-age children. Resistance to traditional chemical-based treatments has become more prevalent in head lice populations, leading to treatment failures and a growing need for alternative and innovative solutions boosts the market demand.

Drugs Insights

Based on the Drugs, the OTC Drugs segment emerged as the dominant player in the global market for Global Lice Treatment Market in 2022 This is primarily because many lice treatment products are available as OTC options, and they are easily accessible to consumers without the need for a prescription. OTC lice treatment products cater to a broad consumer base and are commonly used for the initial management of lice infestations.

Regional Insights

North America emerged as the dominant player in the global Lice Treatment Market in 2022, holding the largest market share. There is a strong emphasis on health education and awareness in North America. Parents, teachers, and healthcare professionals are well-informed about lice infestations, their prevention, and treatment options. This awareness leads to early detection and timely treatment, further boosting the demand for lice treatment products. north America, particularly the United States, has a relatively high prevalence of lice infestations, especially in school-age children.

Key Market Players

• Alliance Pharmaceuticals

• Omega Pharma (Perrigo Company)

• Prestige Brands Holdings Inc.

• Johnson & Johnson

• Fleming Medical Ltd

• RID Lice(Oystershell Consumer Health, Inc)

• Nisarg Pharma

• ParaPRO Pharmaceuticals

• ICB Pharma

• Marico

Report Scope:

In this report, the Global Lice Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Lice Treatment Market, By Type:

• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis

Global Lice Treatment Market, By Drugs:

• OTC Drugs
• Prescription Drugs

Global Lice Treatment Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Lice Treatment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Lice Treatment Market.

Available Customizations:

• Global Lice Treatment Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Lice Treatment Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis)
  • 4.2.2. By Drugs (OTC Drugs, Prescription Drugs)
  • 4.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 4.2.4. By Region
  • 4.2.5. By Company (2022)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Drugs
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Region

5. Asia Pacific Lice Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Drugs
  • 5.2.3. By Distribution Channel
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Lice Treatment Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Drugs
      • 5.3.1.2.3. By Distribution Channel
  • 5.3.2. India Lice Treatment Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Drugs
      • 5.3.2.2.3. By Distribution Channel
  • 5.3.3. Australia Lice Treatment Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Drugs
      • 5.3.3.2.3. By Distribution Channel
  • 5.3.4. Japan Lice Treatment Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Drugs
      • 5.3.4.2.3. By Distribution Channel
  • 5.3.5. South Korea Lice Treatment Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Drugs
      • 5.3.5.2.3. By Distribution Channel

6. Europe Lice Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Drugs
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Lice Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Drugs
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Germany Lice Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Drugs
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Spain Lice Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Drugs
      • 6.3.3.2.3. By Distribution Channel
  • 6.3.4. Italy Lice Treatment Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Drugs
      • 6.3.4.2.3. By Distribution Channel
  • 6.3.5. United Kingdom Lice Treatment Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Drugs
      • 6.3.5.2.3. By Distribution Channel

7. North America Lice Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Drugs
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Lice Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Drugs
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Mexico Lice Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Drugs
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Canada Lice Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Drugs
      • 7.3.3.2.3. By Distribution Channel

8. South America Lice Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Drugs
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Lice Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Drugs
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Argentina Lice Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Drugs
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Colombia Lice Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Drugs
      • 8.3.3.2.3. By Distribution Channel

9. Middle East and Africa Lice Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Drugs
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Lice Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Drugs
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Saudi Arabia Lice Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Drugs
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. UAE Lice Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Drugs
      • 9.3.3.2.3. By Distribution Channel
  • 9.3.4. Egypt Lice Treatment Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Drugs
      • 9.3.4.2.3. By Distribution Channel

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Lice Treatment Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Alliance Pharmaceuticals
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Omega Pharma (Perrigo Company)
• 14.3. Prestige Brands Holdings Inc.
• 14.4. Johnson & Johnson Private Limited
• 14.5. Fleming Medical Ltd
• 14.6. RID Lice(Oystershell Consumer Health, Inc)
• 14.7. Nisarg Pharma
• 14.8. ParaPRO Pharmaceuticals
• 14.9. ICB Pharma
• 14.10. Marico

15. Strategic Recommendations

16. About Us & Disclaimer